Predictors of In-hospital Mortality in Cardiogenic Shock Patients on Vasoactive or Inotropic Support

Background: Though controversial, the short-duration in-patient use of inotropes in cardiogenic shock (CS) remain an ACC/AHA Class IIa indication, and are frequently used in the initial treatment of CS. We evaluated in-patient mortality and effect on mortality risk of commonly used vasoactive inotro...

Full description

Bibliographic Details
Main Authors: Shuktika Nandkeolyar, Tanya Doctorian, Gary Fraser, Rachel Ryu, Colleen Fearon, David Tryon, Whitney Kagabo, Dmitry Abramov, Christopher Hauschild, Liset Stoletniy, Anthony Hilliard, Antoine Sakr
Format: Article
Language:English
Published: SAGE Publishing 2021-10-01
Series:Clinical Medicine Insights: Cardiology
Online Access:https://doi.org/10.1177/11795468211049449